A label-free selected reaction monitoring workflow identifies a subset of pregnancy specific glycoproteins as potential predictive markers of early-onset pre-eclampsia

Richard T. Blankley, Christal Fisher, Melissa Westwood, Robyn North, Philip N. Baker, Michael J. Walker, Andrew Williamson, Anthony D. Whetton, Wanchang Lin, Lesley McCowan, Claire T. Roberts, Garth J.S. Cooper, Richard D. Unwin, Jenny E. Myers

Research output: Contribution to journalArticlepeer-review

36 Citations (Scopus)

Abstract

Pre-eclampsia (PE) is a serious complication of pregnancy with potentially life threatening consequences for both mother and baby. Presently there is no test with the required performance to predict which healthy first-time mothers will go on to develop PE. The high specificity, sensitivity, and multiplexed nature of selected reaction monitoring holds great potential as a tool for the verification and validation of putative candidate biomarkersfor disease states. Realization of this potential involves establishing a high throughput, cost effective, reproducible sample preparation workflow. We have developed a semiautomated HPLC-based sample preparation workflow before a label-free selected reaction monitoring approach. This workflow has been applied to the search for novel predictive biomarkers for PE. To discover novel candidate biomarkers for PE, we used isobaric tagging to identify several potential biomarker proteins in plasma obtained at 15 weeks gestation from nulliparous women who later developed PE compared with pregnant women who remained healthy. Such a study generates a number of "candidate" biomarkers that require further testing in larger patient cohorts. As proof-of-principle, two of these proteins were taken forward for verification in a 100 women (58 PE, 42 controls) using label-free SRM. We obtained reproducible protein quantitation across the 100 samples and demonstrated significant changes in protein levels, even with as little as 20% change in protein concentration. The SRM data correlated with a commercial ELISA, suggesting that this is a robust workflow suitable for rapid, affordable, label-free verification of which candidate biomarkers should be taken forward for thorough investigation. A subset of pregnancyspecific glycoproteins (PSGs) had value as novel predictive markers for PE.

Original languageEnglish
Pages (from-to)3148-3159
Number of pages12
JournalMolecular and Cellular Proteomics
Volume12
Issue number11
DOIs
Publication statusPublished - 1 Nov 2013
Externally publishedYes

Fingerprint Dive into the research topics of 'A label-free selected reaction monitoring workflow identifies a subset of pregnancy specific glycoproteins as potential predictive markers of early-onset pre-eclampsia'. Together they form a unique fingerprint.

Cite this